130 related articles for article (PubMed ID: 25695330)
1. Anti-leukemic effect of sodium metaarsenite (KML001) in acute myeloid leukemia with breaking-down the resistance of cytosine arabinoside.
Yoon JS; Kim ES; Park BB; Choi JH; Won YW; Kim S; Lee YY
Int J Oncol; 2015 May; 46(5):1953-62. PubMed ID: 25695330
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin's lymphoma: an in vitro and in vivo study.
Yoon JS; Hwang DW; Kim ES; Kim JS; Kim S; Chung HJ; Lee SK; Yi JH; Uhm J; Won YW; Park BB; Choi JH; Lee YY
Invest New Drugs; 2016 Feb; 34(1):1-14. PubMed ID: 26581399
[TBL] [Abstract][Full Text] [Related]
3. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
[TBL] [Abstract][Full Text] [Related]
4. KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells.
Liu Y; Shin DY; Oh S; Kim S; Koh Y; Kim I
Oncol Rep; 2017 Jul; 38(1):481-487. PubMed ID: 28586017
[TBL] [Abstract][Full Text] [Related]
5. Anti-Tumor Effects of Sodium Meta-Arsenite in Glioblastoma Cells with Higher Akt Activities.
Lee EJ; Sung JY; Koo KH; Park JB; Kim DH; Shim J; Lee CH; Park J; Kim YN
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256086
[TBL] [Abstract][Full Text] [Related]
6. Antitumoral effect of arsenic compound, sodium metaarsenite (KML001), on multiple myeloma cells.
Kim SJ; Kim ES; Kim S; Uhm J; Won YW; Park BB; Choi JH; Lee YY
Int J Oncol; 2017 Dec; 51(6):1739-1746. PubMed ID: 29039521
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia.
Zhe N; Wang J; Chen S; Lin X; Chai Q; Zhang Y; Zhao J; Fang Q
Hematology; 2015 Aug; 20(7):384-91. PubMed ID: 26218201
[TBL] [Abstract][Full Text] [Related]
8. KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway.
You D; Kim Y; Jang MJ; Lee C; Jeong IG; Cho YM; Hwang JJ; Hong JH; Ahn H; Kim CS
PLoS One; 2015; 10(9):e0137589. PubMed ID: 26352139
[TBL] [Abstract][Full Text] [Related]
9. A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
Sumi M; Tauchi T; Sashida G; Nakajima A; Gotoh A; Shin-Ya K; Ohyashiki JH; Ohyashiki K
Int J Oncol; 2004 Jun; 24(6):1481-7. PubMed ID: 15138591
[TBL] [Abstract][Full Text] [Related]
10. KML001 inhibits cell proliferation and invasion in pancreatic cancer cells through suppression of NF-κB and VEGF-C.
Yang MH; Kim HT; Lee KT; Yang S; Lee JK; Lee KH; Rhee JC
Anticancer Res; 2014 Jul; 34(7):3469-74. PubMed ID: 24982355
[TBL] [Abstract][Full Text] [Related]
11. Anti-leukemic effect of 2-pyrone derivatives via MAPK and PI3 kinase pathways.
Yoon JS; Won YW; Kim SJ; Oh SJ; Kim ES; Kim BK; Cho CG; Choi JH; Park BB; Lee MH; Lee YY
Invest New Drugs; 2012 Dec; 30(6):2284-93. PubMed ID: 22526834
[TBL] [Abstract][Full Text] [Related]
12. Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine.
Kim Y; Eom JI; Jeung HK; Jang JE; Kim JS; Cheong JW; Kim YS; Min YH
Biomed Pharmacother; 2015 Jul; 73():87-96. PubMed ID: 26211587
[TBL] [Abstract][Full Text] [Related]
13. Anti-leukemic effect of a synthetic compound, (±) trans-dihydronarciclasine (HYU-01) via cell-cycle arrest and apoptosis in acute myeloid leukemia.
Kim SJ; Park HK; Kim JY; Yoon JS; Kim ES; Cho CG; Kim BK; Park BB; Lee YY
APMIS; 2012 Oct; 120(10):836-45. PubMed ID: 22958292
[TBL] [Abstract][Full Text] [Related]
14. Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines.
Lishner M; Bar-Sef A; Elis A; Fabian I
J Investig Med; 2001 Jul; 49(4):319-24. PubMed ID: 11478407
[TBL] [Abstract][Full Text] [Related]
15. Alleviation of the drug-resistant phenotype in idarubicin and cytosine arabinoside double-resistant acute myeloid leukemia cells by indomethacin.
Song JH; Kim SH; Kim HJ; Hwang SY; Kim TS
Int J Oncol; 2008 Apr; 32(4):931-6. PubMed ID: 18360721
[TBL] [Abstract][Full Text] [Related]
16. Cytarabine-resistant leukemia cells are moderately sensitive to clofarabine in vitro.
Yamauchi T; Uzui K; Nishi R; Shigemi H; Ueda T
Anticancer Res; 2014 Apr; 34(4):1657-62. PubMed ID: 24692694
[TBL] [Abstract][Full Text] [Related]
17. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
18. The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.
Spinello I; Saulle E; Quaranta MT; Pasquini L; Pelosi E; Castelli G; Ottone T; Voso MT; Testa U; Labbaye C
Haematologica; 2019 May; 104(5):973-985. PubMed ID: 30467201
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in retinoid-refractory acute myelogenous leukemia by a novel AHPN analog.
Zhang Y; Dawson MI; Ning Y; Polin L; Parchment RE; Corbett T; Mohamed AN; Feng KC; Farhana L; Rishi AK; Hogge D; Leid M; Peterson VJ; Zhang XK; Mohammad R; Lu JS; Willman C; VanBuren E; Biggar S; Edelstein M; Eilender D; Fontana JA
Blood; 2003 Nov; 102(10):3743-52. PubMed ID: 12893763
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis.
Liu N; Wang C; Wang L; Gao L; Cheng H; Tang G; Hu X; Wang J
Int J Mol Med; 2016 Jun; 37(6):1686-96. PubMed ID: 27082972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]